Medclair AB (NGM: MCLR)

Market Cap	148.07M
Revenue (ttm)	50.30M
Net Income (ttm)	2.43M
Shares Out	82.49M
EPS (ttm)	0.03
PE Ratio	70.40
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	135,401
Open	n/a
Previous Close	1.830
Day's Range	n/a
52-Week Range	1.080 - 2.240
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 1, 2024

About Medclair AB

Medclair AB, a research and development company, specializes in the measurement, collection, and destruction of nitrous oxide (N2O). It offers mobile destruction unit, a solution that can be moved anywhere, where N2O is needed for pain relief; central destruction unit, a system designed for larger N2O destruction volumes; exhalation device that addresses the problem with residual levels of N2O in the patient’s exhalation; collection units for non-frequent use of N2O, and less frequent use or fitting in emergency services vehicles; and Nitrous O...

• Industry: Crude Petroleum and Natural Gas
• Founded: 2008
• Employees: 14
• Stock Exchange: Nordic Growth Market
• Ticker Symbol: MCLR

Financial Performance

In 2023, Medclair AB's revenue was 42.42 million, an increase of 50.60% compared to the previous year's 28.17 million. Losses were -2.79 million, -44.30% less than in 2022.